PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Value in Health10.1016/j.jval.2016.08.4852016197A849To Evaluate the Outcomes of Concomitant Chemoradiotherapy Followed by Extended Adjuvant Temozolomide in Patients with Newly Diagnosed Glioblastoma - A Retrospective StudyS Gupta, SK Gupta, R Mathurhttps://api.elsevier.com/content/article/PII:S1098301516310658?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1098301516310658?httpAccept=text/plain
Journal of Neuro-Oncology10.1007/s11060-008-9576-72008883353-357A retrospective study of the safety of BCNU wafers with concurrent temozolomide and radiotherapy and adjuvant temozolomide for newly diagnosed glioblastoma patientsEdward Pan, Susan B. Mitchell, Jerry S. Tsaihttp://link.springer.com/content/pdf/10.1007/s11060-008-9576-7.pdf, http://link.springer.com/article/10.1007/s11060-008-9576-7/fulltext.html, http://link.springer.com/content/pdf/10.1007/s11060-008-9576-7
Oncology10.1159/000488395201895139-42Interim Results of a Phase II Study of Hypofractionated Radiotherapy with Concurrent Temozolomide Followed by Adjuvant Temozolomide in Patients over 70 Years Old with Newly Diagnosed GlioblastomaMehran Yusuf, Beatrice Ugiliweneza, Mark Amsbaugh, Maxwell Boakye, Brian Williams, Megan Nelson, Eyas M. Hattab, Shiao Woo, Eric Burtonhttps://www.karger.com/Article/Pdf/488395, https://www.karger.com/Article/Pdf/488395
Neuro-Oncology10.1093/neuonc/noz175.044201921Supplement_6vi11-vi12ATIM-46. A MULTICENTER, PHASE I, TRIAL OF RADIATION, TEMOZOLOMIDE AND RRx-001 FOLLOWED BY MAINTENANCE TEMOZOLOMIDE WITH OR WITHOUT RRx-001 IN NEWLY DIAGNOSED GLIOBLASTOMA PATIENTSRobert Aiken, Howard Fine, Nicholas Butowskihttp://academic.oup.com/neuro-oncology/article-pdf/21/Supplement_6/vi11/30632693/noz175.044.pdf, http://academic.oup.com/neuro-oncology/article-pdf/21/Supplement_6/vi11/30632693/noz175.044.pdf
Neuro-Oncology Advances10.1093/noajnl/vdab112.03620213Supplement_4iv10-iv10SYST-08. A phase II trial of concurrent Sunitinib, Temozolomide and Radiation Therapy followed by adjuvant Temozolomide for newly diagnosed Glioblastoma patients with an unmethylated MGMT gene promoter (A01-M121-11A, McG1132)Mame Daro Faye, Siham Sabri, Paula De Robles, Raman Agnihotram, Alexander Torres-Vasquez, Jacob Easaw, Bassam Abdulkarimhttp://academic.oup.com/noa/article-pdf/3/Supplement_4/iv10/40414449/vdab112.036.pdf, http://academic.oup.com/noa/article-pdf/3/Supplement_4/iv10/40414449/vdab112.036.pdf
Yearbook of Neurology and Neurosurgery10.1016/j.yneu.2011.04.05020112011143-144Phase I/IIa Study of Cilengitide and Temozolomide With Concomitant Radiotherapy Followed by Cilengitide and Temozolomide Maintenance Therapy in Patients With Newly Diagnosed GlioblastomaJ. Uhmhttps://api.elsevier.com/content/article/PII:S0513511711000688?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0513511711000688?httpAccept=text/plain
International Journal of Radiation Oncology*Biology*Physics10.1016/j.ijrobp.2022.07.66820221143S169A Phase II Trial of Concurrent Sunitinib, Temozolomide and Radiation Therapy Followed by Adjuvant Temozolomide for Newly Diagnosed Glioblastoma Patients with an Unmethylated MGMT Gene PromoterM.D. Faye, S. Sabri, P. De Robles, R. Agnihotram, A. Torres-Vasquez, V. Panet-Raymond, G. Shenouda, L. Souhami, J. Esaw, B.S. Abdulkarimhttps://api.elsevier.com/content/article/PII:S036030162201389X?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S036030162201389X?httpAccept=text/plain
Neuro-Oncology10.1093/neuonc/noz175.047201921Supplement_6vi12-vi12ACTR-03. FINAL RESULTS OF A PHASE II STUDY OF HYPOFRACTIONATED RADIOTHERAPY WITH CONCURRENT AND ADJUVANT TEMOZOLOMIDE IN PATIENTS OVER 70 YEARS OLD WITH NEWLY DIAGNOSED GLIOBLASTOMAMehran Yusuf, Jeremy Gaskins, Shiao Woo, Eric Burtonhttp://academic.oup.com/neuro-oncology/article-pdf/21/Supplement_6/vi12/30633137/noz175.047.pdf, http://academic.oup.com/neuro-oncology/article-pdf/21/Supplement_6/vi12/30633137/noz175.047.pdf
Radiotherapy and Oncology10.1016/s0167-8140(22)04283-92022174S54: A Phase II Trial of Concurrent Sunitinib, Temozolomide and Radiation Therapy Followed by Adjuvant Temozolomide for Newly Diagnosed Glioblastoma Patients with an Unmethylated MGMT Gene Promoter (A01-M121-11A, MCG1132)Mame Daro Faye, Siham Sabri, Paula De Robles, Jacob Easaw, Raman Agnihotram, Alexander Torres-Vasquez, Valerie Panet-Raymond, George Shenouda, Luis Souhami, Bassam Abdulkarimhttps://api.elsevier.com/content/article/PII:S0167814022042839?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0167814022042839?httpAccept=text/plain
Neuro-Oncology10.1093/neuonc/noab196.176202123Supplement_6vi45-vi45RADT-18. NEOADJUVANT (PRE RADIOTHERAPY) TEMOZOLOMIDE FOLLOWED BY RADIATION THERAPY WITH CONCURRENT AND ADJUVANT TEMOZOLOMIDE IN GLIOBLASTOMA MULTIFORMEChinmaykumar Prajapati, Maitrik Mehta, U Suryanarayan Kunikullayahttps://academic.oup.com/neuro-oncology/article-pdf/23/Supplement_6/vi45/41141150/noab196.176.pdf, https://academic.oup.com/neuro-oncology/article-pdf/23/Supplement_6/vi45/41141150/noab196.176.pdf